Oriel Research Therapeutics (ORT) is a bioinformatics company that provides services both for harmonized real-world patients derived genomic data and for blood based early detection tests for cancer and other diseases.
ORT's technology utilizes a state-of-the-art cloud based software platform, which processes large omic (specifically gene expressions), and clinical data to build the ORT database. The database is processed with proprietary Artificial Intelligence/Machine Learning (Al/ML) models to develop blood based early detection tests for various medical conditions (including cancer), and to identify novel targets.
The ORT database has over 1 million RNA-seq profiles, including bulk and single cell sequencing data, from in-vivo and in-vitro patients samples with matching clinical data.
Oriel Research Therapeutics allows easy access to its large scale, harmonized, real world data (RWD) and its proprietary pipelines to allow a quick adoption of evidence based diagnosis and therapies with the ultimate goal of improving human health.